Evidence map›Paper›PMID 38644814›Full record

ArticleHeliyon2024

Phenolic profiling and bioactivity assessment of

Eman M El-Deeb, Heba E Elsayed, Hanaa B Ateya, Hussein S Taha, Mohamed R Elgindi, Doaa Abouelenein, Giovanni Caprioli, Kuei-Hung Lai, Ahmed M Mustafa, Fatma A Moharram

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Anti-psoriatic potential of nanocarrier formulated with Deverra tortuosa DC. and Deverra triradiata hochst aerial extracts: in vivo evaluation in mice.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  3. Review
  4. Molecules (Basel, Switzerland) · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman M El-DeebDepartment of Pharmacognosy, Faculty of Pharmacy, October 6 University, Giza, Egypt.
Heba E ElsayedDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
Hanaa B AteyaDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
Hussein S TahaDepartment of Plant Biotechnology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
Mohamed R ElgindiDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
Doaa AboueleneinSchool of Pharmacy, University of Camerino, via Sant' Agostino 1, Camerino, Italy.
Giovanni CaprioliSchool of Pharmacy, University of Camerino, via Sant' Agostino 1, Camerino, Italy.
Kuei-Hung LaiGraduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Ahmed M MustafaSchool of Pharmacy, University of Camerino, via Sant' Agostino 1, Camerino, Italy.
Fatma A MoharramDepartment of Pharmacognosy, Faculty of Pharmacy, Helwan University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-cancerAnti-inflammatoryAntioxidantCallusHPLC-MS/MSMicropropagationPhenolicsRegeneration

Identifiers

PMID38644814
PMCPMC11033136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.